Evaluation of XIENCE Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization
Principal Investigator
Jaap N. HamburgerOverview
Body Locations and Systems
Diagnosis and Therapy
ClinicalTrials.gov#
NCT01205776Status
Closed for RecruitmentStudy Start/End
Apr 26, 2011 to Jan 31, 2021Locations
Vancouver General HospitalName/Title
Andriy Starovoytov, Research CoordinatorPhone
604-875-5079Email Address
a.starovoytov@ubc.caPurpose of Study
To establish the safety and efficacy of the commercially approved XIENCE Family Stent System (inclusive of XIENCE PRIME, XIENCE V, XIENCE Xpedition and XIENCE PRO [for use outside the United States [OUS] only]) in subjects with unprotected left main coronary artery disease by comparing to coronary artery bypass graft surgery.
Eligibility
Visit ClinicalTrials.gov for more information.
Disclaimer
Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.